End-stage Renal Disease
📧 Sign up to get email alerts when something new happens for End-stage Renal Disease.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2013-07-02Clinical Trial Update: Evaluation of the GORE® ACUSEAL Vascular Graft for Hemodialysis Access [Phase 2, Phase 3]
Phase 2/3 trial evaluating the GORE ACUSEAL Vascular Graft for hemodialysis access has completed with results posted in 2013.
-
CLINICAL_TRIALS trial_result · 2013-06-20Clinical Trial Update: Study of Inflammation and Oxidative Stress in Persons Undergoing Dialysis [Phase 2]
Phase 2 clinical trial evaluating inflammation and oxidative stress in adults with end-stage renal disease on dialysis; results have been po…
-
CLINICAL_TRIALS trial_result · 2013-06-13Clinical Trial Update: Uremic Toxin Removal and Hemodynamics in Long-hour Hemodialysis and Hemodiafiltration [NA]
A completed clinical trial from Maastricht University Medical Center evaluated uremic toxin removal and hemodynamic stability in long-hour h…
-
CLINICAL_TRIALS trial_result · 2013-06-12Clinical Trial Update: Study of Everolimus in de Novo Renal Transplant Recipients [NA]
This is a clinical trial update on everolimus in de novo renal transplant recipients; the study has been terminated.
-
CLINICAL_TRIALS trial_result · 2013-06-11Clinical Trial Update: Evaluating Safety and Efficacy of TOL101 Induction Versus Anti-Thymocyte Globulin to Prevent Kidney Transplant Rejection [Phase 1, Phase 2]
A Phase 1/2 clinical trial evaluating TOL101 induction versus anti-thymocyte globulin to prevent kidney transplant rejection, assessing safe…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2013-06-10Clinical Trial Update: Effect of 25-hydroxyvitamin D and a Structured Exercise Program on Dialysis Patients [Phase 4]
This Phase 4 trial update reports completion of a study evaluating whether adding 25-hydroxyvitamin D and a structured exercise program bene…
-
CLINICAL_TRIALS trial_result · 2013-06-07Clinical Trial Update: Short- and Long-Term Impact of Subtotal Parathyroidectomy on the Achievement of Bone and Mineral Parameters Recommended by Clinical Practice Guidelines in Dialysis Patients
A completed clinical trial assessing the short- and long-term impact of subtotal parathyroidectomy on bone and mineral parameters in dialysi…
-
CLINICAL_TRIALS trial_result · 2013-06-06Clinical Trial Update: Comparison of Efficacy and Safety of Paricalcitol Injection With Maxacalcitol Injection in Adult Japanese Chronic Kidney Disease Subjects Receiving Hemodialysis With Secondary Hyperparathyroidism [Phase 3]
Phase 3 trial comparing paricalcitol injections with maxacalcitol injections in adult Japanese CKD patients on hemodialysis with secondary h…
-
CLINICAL_TRIALS research · 2013-06-05Clinical Trial Update: Risk Assessment of Peritoneal Dialysis Failure Based on Catheter Tip Location.
An ongoing clinical trial assessing whether catheter tip location influences the risk of peritoneal dialysis failure.
-
CLINICAL_TRIALS trial_result · 2013-05-30Clinical Trial Update: Chronotherapy Versus Conventional BP Control to Correct Abnormal Circadian BP Pattern in Kidney Transplant Recipients [NA]
A completed Mayo Clinic trial compared chronotherapy (timing of antihypertensive treatment) versus conventional blood pressure control to co…
-
CLINICAL_TRIALS trial_result · 2013-05-29Clinical Trial Update: Vitamin D3 Supplementation in Dialysis Patients [Phase 2]
A Phase 2 clinical trial evaluating Vitamin D3 (cholecalciferol) supplementation in patients with End-Stage Renal Disease has completed.
-
CLINICAL_TRIALS trial_result · 2013-05-23Clinical Trial Update: SENSOR: Study to Investigate Cinacalcet Treatment in Haemodialysis Patients With Secondary Hyperparathyroidism [Phase 3]
This document notes the completion of the Phase 3 SENSOR trial evaluating cinacalcet for secondary hyperparathyroidism in patients on haemod…
-
CLINICAL_TRIALS trial_result · 2013-05-15Clinical Trial Update: Fiber Intake in an End Stage Renal Disease (ESRD) Population Followed Over 2 Years
A completed clinical trial evaluating the impact of dietary fiber intake on cardiovascular outcomes, potassium control, and lipid profile in…
-
CLINICAL_TRIALS trial_result · 2013-05-14Clinical Trial Update: Effect of Turmeric on Pruritus in Hemodialysis Patients [EARLY_Phase 1]
This update notes the completion of an EARLY Phase 1 trial evaluating turmeric for pruritus in patients undergoing hemodialysis due to end-s…
-
CLINICAL_TRIALS trial_result · 2013-05-13Clinical Trial Update: Research Study Evaluating Cinacalcet for Patients With End Stage Renal Disease (ESRD) [Phase 2]
Phase 2 clinical trial evaluating cinacalcet for end stage renal disease has completed.
-
CLINICAL_TRIALS trial_result · 2013-05-13Clinical Trial Update: Cinacalcet Study to Reach Kidney Disease Outcomes Quality Initiative (K/DOQI) Levels [Phase 2]
Phase 2 trial of cinacalcet in end-stage renal disease sponsored by Amgen has completed. The study aimed to reach Kidney Disease Outcomes Qu…
-
CLINICAL_TRIALS trial_result · 2013-05-08Clinical Trial Update: A Study of an Investigational Medication for the Treatment of Secondary Hyperparathyroidism in Dialysis Patients [Phase 3]
This entry reports the completion of a Phase 3 study evaluating an investigational medication for secondary hyperparathyroidism in patients …
-
CLINICAL_TRIALS trial_result · 2013-05-08Clinical Trial Update: A Study of an Investigational Medication for the Treatment of Secondary Hyperparathyroidism in Patients on Dialysis [Phase 3]
Phase 3 clinical trial of an investigational medication for secondary hyperparathyroidism in patients on dialysis has completed.
-
CLINICAL_TRIALS trial_result · 2013-05-08Clinical Trial Update: NESP Pediatric Study [Phase 3]
Amgen reports completion of the Phase 3 pediatric trial of NESP for patients with chronic kidney disease including pre-dialysis and end-stag…
-
CLINICAL_TRIALS trial_result · 2013-05-08Clinical Trial Update: Oral Paricalcitol in Kidney Transplant Recipients [NA]
A completed clinical trial evaluated oral paricalcitol in kidney transplant recipients. Results were posted in 2013.
-
CLINICAL_TRIALS withdrawal · 2013-05-08Clinical Trial Update: Calcineurin Inhibitor-free, Steroid-free Immunosuppressive Regimen in Simultaneous Islet-Kidney Transplantation for Uremic Type 1 Diabetic Patients [NA]
The trial evaluating a calcineurin inhibitor-free, steroid-free immunosuppressive regimen for simultaneous islet-kidney transplantation in u…
-
FDA approval · 2013-04-26FDA Approved: EXTRANEAL — Supplemental Application (Vantive US Healthcare LLC)
FDA approved a supplemental application for Extraneal (icodextrin) submitted by Vantive US Healthcare LLC.
-
FDA approval · 2013-04-26FDA Approved: DIANEAL LOW CALCIUM WITH DEXTROSE — Supplemental Application (Vantive US Healthcare LLC)
FDA approved a supplemental application for DIANEAL LOW CALCIUM WITH DEXTROSE, a peritoneal dialysis solution from Vantive US Healthcare LLC…
-
FDA approval · 2013-04-26FDA Approved: DIANEAL LOW CALCIUM WITH DEXTROSE — Supplemental Application (Vantive US Healthcare LLC)
FDA approves a supplemental application for Dianeal Low Calcium with Dextrose, adding a low-calcium peritoneal dialysis solution variant to …
-
FDA approval · 2013-04-26FDA Approved: DIANEAL PD-2 WITH DEXTROSE — Supplemental Application (Vantive US Healthcare LLC)
The FDA approved a supplemental application for Dianeal PD-2 with Dextrose, a peritoneal dialysis solution, with manufacturing by Vantive US…